
Sign up to save your podcasts
Or


Jeremy and Ryan discuss generic and biosimilar drugs in the context of what they are, how they come to exist, patents, and future opportunities.
We welcome your questions or comments on this subject or others. To contact us you may email Jeremy directly at [email protected].
By Jeremy Schmerer, Ryan LaRanger, Maikel Boot, & Joao Guerreiro5
44 ratings
Jeremy and Ryan discuss generic and biosimilar drugs in the context of what they are, how they come to exist, patents, and future opportunities.
We welcome your questions or comments on this subject or others. To contact us you may email Jeremy directly at [email protected].